{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:49:04Z","timestamp":1777589344679,"version":"3.51.4"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T00:00:00Z","timestamp":1379635200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0073555","type":"journal-article","created":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T21:08:16Z","timestamp":1379711296000},"page":"e73555","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Oncolytic Reovirus in Canine Mast Cell Tumor"],"prefix":"10.1371","volume":"8","author":[{"given":"Chung Chew","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Umeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiharu","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Hiraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matt","family":"Coffey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,9,20]]},"reference":[{"key":"ref1","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"A Jemal","year":"2011","journal-title":"CA: A cancer journal for clinicians"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Butler LM, Bonnett BN, Page RL (2013) Epidemiology and the evidence-based medicine approach. In: Withrow SJ, Vail DM, Page RL, editors. Small animal clinical oncology. Missouri: Elsevier Saunders. 68\u201382.","DOI":"10.1016\/B978-1-4377-2362-5.00004-9"},{"key":"ref3","first-page":"156","article-title":"Oncolytic viruses in cancer therapy","volume":"40","author":"S Meerani","year":"2010","journal-title":"Eur J Sci Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1479-5876-10-3","article-title":"Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients","volume":"10","author":"SS Patil","year":"2012","journal-title":"J Transl Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0166-0934(94)90062-0","article-title":"A study of human reovirus IgG and IgA antibodies by ELISA and western blot","volume":"47","author":"B Selb","year":"1994","journal-title":"J Virol Methods"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1182\/blood-2002-02-0503","article-title":"Reovirus therapy of lymphoid malignancies","volume":"100","author":"T Alain","year":"2002","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1158\/0008-5472.CAN-09-2408","article-title":"Oncolytic viral therapy for prostate cancer: efficacy of reovirus as a biological therapeutic","volume":"70","author":"CM Thirukkumaran","year":"2010","journal-title":"Cancer Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1158\/1078-0432.CCR-10-2159","article-title":"A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer","volume":"17","author":"MP Lolkema","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1128\/JVI.28.2.444-449.1978","article-title":"Differential sensitivity of normal and transformed human cells to reovirus infection","volume":"28","author":"MR Duncan","year":"1978","journal-title":"J Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/JVI.70.1.612-616.1996","article-title":"The v-erbB oncogene confers enhanced cellular susceptibility to reovirus infection","volume":"70","author":"JE Strong","year":"1996","journal-title":"J Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1093\/emboj\/17.12.3351","article-title":"The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus","volume":"17","author":"JE Strong","year":"1998","journal-title":"EMBO J"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1126\/science.282.5392.1332","article-title":"Reovirus therapy of tumors with activated Ras pathway","volume":"282","author":"MC Coffey","year":"1998","journal-title":"Science"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/1471-2407-12-368","article-title":"Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway","volume":"12","author":"K Twigger","year":"2012","journal-title":"BMC Cancer"},{"key":"ref14","first-page":"185","article-title":"Regulation of normal and neoplastic human mast cell development in mastocytosis","volume":"116","author":"DD Metcalfe","year":"2005","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"London CA, Thamm DH (2013) Mast cell tumors. In: Withrow SJ, Vail DM, Page RL, editors. Small animal clinical oncology. Missouri: Elsevier Saunders. 335\u2013355.","DOI":"10.1016\/B978-1-4377-2362-5.00020-7"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/mc.1027","article-title":"Comparative analysis of <italic>ras<\/italic> proto-oncogene mutations in selected mammalian tumors","volume":"30","author":"F Watzinger","year":"2001","journal-title":"Mol Carcinog"},{"key":"ref17","first-page":"3027","article-title":"Absence of ras-gene hot-spot mutations in canine fibrosarcomas and melanomas","volume":"24","author":"H Murua Escobar","year":"2004","journal-title":"Anticancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/ilar.51.3.214","article-title":"Modeling opportunities in comparative oncology for drug development","volume":"51","author":"IK Gordon","year":"2010","journal-title":"ILAR Journal"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000053820","article-title":"IgG-mediated histamine release from canine mastocytoma-derived cells","volume":"125","author":"T Takahashi","year":"2001","journal-title":"Int Arch Allergy Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1292\/jvms.63.1031","article-title":"Establishment and characterization of a new canine mast cell tumor cell line","volume":"63","author":"T Ishiguro","year":"2001","journal-title":"J Vet Med Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vetimm.2008.06.014","article-title":"Identification of c-kit mutations-independent neoplastic cell proliferation of canine mast cells","volume":"126","author":"K Ohmori","year":"2008","journal-title":"Vet Immunol Immunopathol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"LJ Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0076-6879(01)33067-7","article-title":"Nonradioactive determination of Ras-GTP levels using activated ras interaction assay","volume":"333","author":"SJ Taylor","year":"2001","journal-title":"Meth Enzymol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.vetimm.2011.04.009","article-title":"Characterization of monoclonal antibodies against canine P-selectin glycoprotein ligand-1 (PSGL-1)","volume":"142","author":"S Umeki","year":"2011","journal-title":"Vet Immunol Immunopathol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.vetimm.2006.03.024","article-title":"Generation and characterization of bone marrow-derived cultured canine mast cells","volume":"113","author":"T-Y Lin","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1292\/jvms.09-0281","article-title":"Cultivation and characterization of canine skin-derived mast cells","volume":"72","author":"S Kawarai","year":"2009","journal-title":"J Vet Med Sci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-1-60761-869-0_15","article-title":"Antiinflammatory and immunosuppressive functions of mast cells","volume":"677","author":"J Kalesnikoff","year":"2011","journal-title":"Methods Mol Biol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/sj.mt.6300179","article-title":"Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release","volume":"15","author":"P Marcato","year":"2007","journal-title":"Mol Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"734","DOI":"10.4161\/cbt.3.8.963","article-title":"Morbidity in immunosuppressed (SCID\/NOD) mice treated with reovirus (Dearing 3) as an anti-cancer biotherapeutic","volume":"3","author":"SD Loken","year":"2004","journal-title":"Cancer Biol Ther"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood-2002-08-2508","article-title":"Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation","volume":"102","author":"CM Thirukkumaran","year":"2003","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/cgt.2008.2","article-title":"Transient infection of freshly isolated human colorectal tumor cells by reovirus T3D intermediate subviral particles","volume":"15","author":"WJ van Houdt","year":"2008","journal-title":"Cancer Gene Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1476-4598-8-47","article-title":"Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells","volume":"8","author":"S Sei","year":"2009","journal-title":"Mol Cancer"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/gt.2008.58","article-title":"Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma","volume":"15","author":"F Errington","year":"2008","journal-title":"Gene Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"11099","DOI":"10.1073\/pnas.0404310101","article-title":"Reovirus oncolysis: the Ras\/RalGEF\/p38 pathway dictates host cell permissiveness to reovirus infection","volume":"101","author":"KL Norman","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1038\/onc.2010.137","article-title":"The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status","volume":"29","author":"M Kim","year":"2010","journal-title":"Oncogene"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e54006","DOI":"10.1371\/journal.pone.0054006","article-title":"Activation of p53 by chemotherapeutic agents enhances reovirus oncolysis","volume":"8","author":"D Pan","year":"2013","journal-title":"PLoS ONE"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0092-8674(01)00231-8","article-title":"Junction adhesion molecule is a receptor for reovirus","volume":"104","author":"ES Barton","year":"2001","journal-title":"Cell"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1128\/JVI.71.3.1834-1841.1997","article-title":"Mutations in type 3 reovirus that determine binding to sialic acid are contained in the fibrous tail domain of viral attachment protein sigma1","volume":"71","author":"JD Chappell","year":"1997","journal-title":"J Virol"},{"key":"ref39","first-page":"1023","article-title":"Reovirus infection induces apoptosis of TRAIL-resistant gastric cancer cells by down-regulation of Akt activation","volume":"36","author":"I-R Cho","year":"2010","journal-title":"Int J Oncol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"13132","DOI":"10.1128\/JVI.78.23.13132-13138.2004","article-title":"JNK regulates the release of proapoptotic mitochondrial factors in reovirus-infected cells","volume":"78","author":"P Clarke","year":"2004","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1128\/JVI.74.7.2981-2989.2000","article-title":"Reovirus-induced apoptosis requires activation of transcription factor NF-\u03baB","volume":"74","author":"JL Connolly","year":"2000","journal-title":"J Virol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.bbrc.2005.09.150","article-title":"Structure and regulation of Kit protein-tyrosine kinase\u2013the stem cell factor receptor","volume":"338","author":"R Roskoski","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1200\/JCO.20.6.1692","article-title":"Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies","volume":"20","author":"MC Heinrich","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2885.2011.01296.x","article-title":"Biological effect of tyrosine kinase inhibitors on three canine mast cell tumor cell lines with various KIT statuses","volume":"35","author":"Y Takeuchi","year":"2012","journal-title":"J Vet Pharmacol Ther"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/ijc.27918","article-title":"Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cells","volume":"132","author":"RA Adair","year":"2012","journal-title":"Int J Cancer"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1158\/1078-0432.CCR-10-3266","article-title":"Internalization of oncolytic reovirus by human dendritic cell carriers protects the virus from neutralization","volume":"17","author":"EJ Ilett","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.4049\/jimmunol.180.9.6018","article-title":"Reovirus activates human dendritic cells to promote innate antitumor immunity","volume":"180","author":"F Errington","year":"2008","journal-title":"J Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7883\/yoken1952.22.13","article-title":"Serological epidemiology of reovirus infection","volume":"22","author":"H Fukumi","year":"1969","journal-title":"Jpn J Med Sci Biol"},{"key":"ref49","first-page":"8","article-title":"Reovirus antibody patterns in dogs: a trial for the application of principal component analysis to seroepidemiology","volume":"15","author":"T Murakami","year":"1975","journal-title":"Natl Inst Anim Health Q (Tokyo)"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vetmic.2005.05.014","article-title":"Virological and molecular characterization of a mammalian orthoreovirus type 3 strain isolated from a dog in Italy","volume":"109","author":"N Decaro","year":"2005","journal-title":"Vet Microbiol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1089\/hum.2009.135","article-title":"The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon","volume":"20","author":"RJ Prestwich","year":"2009","journal-title":"Hum Gene Ther"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0073555","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T13:38:15Z","timestamp":1596548295000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0073555"}},"subtitle":[],"editor":[{"given":"Brian","family":"Lichty","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,9,20]]},"references-count":51,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,9,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0073555","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,20]]}}}